Shari D. Bolen, MD, MPH MetroHealth/CWRU Assistant Professor of Medicine, Epidemiology & Biostatistics I have no COI Define a systematic review and metaanalysis Explain the steps and timeline for a high quality systematic review Discuss uses of systematic reviews for CER Discuss novel areas for growth in systematic reviews conducting CER Potential funding sources Systematic review: a summary of existing research using reproducible methods Meta-analysis: a statistical approach to combining data from individual studies Define question Establish eligibility criteria Search literature & review citations Extract data Evaluate study quality & applicability Summarize & synthesize Determine priorities ◦ Identify areas of controversy (do guidelines or experts conflict?) Formulate in specific measurable terms ◦ Use a structured approach to frame each question (PICOTS) Be specific about: ◦ Population: Adults with Type 2 diabetes ◦ Intervention: TZDs, biguanides, SUs, alphaglucosidase inhibitors; meglitinides ◦ Comparison: head to head and indirect; monotherapy ◦ Outcomes: intermediate, long term, and safety ◦ Time: studies>3 months ◦ Setting: no limits Select highest yield sources Consider other sources (CINAHL, ERIC, CancerLit, FDA, etc…) ◦ MEDLINE®/PubMed ◦ EMBASE® ◦ Cochrane database of reviews & trials ◦ Use sampling to estimate incremental yield Use hand searches for quality control ◦ Citations in eligible articles ◦ Table of contents of relevant journals ◦ Query experts Develop strategy in Pubmed then translate to other websites Use literature on search strategies (BMJ) For diabetes medications, we used the terms: type 2 diabetes and the individual generic and brand names of the medications Title review (n=7,563) Title review: 5,157 excluded Abstract review (n=2,406) Abstract review: 1,972 excluded Full-text review (n=434) Full-text review: 218 excluded 216 included articles Extract data using standardized data extraction forms Sequential or Independent dual review Discuss and resolve discrepancies Use established instruments for quality assessment (Jadad, Strobe) Assemble evidence tables Summarize results Perform meta-analyses if indicated GRADE strength of the evidence Often takes 1-3 years to conduct a high quality systematic review Budget: can do unfunded if fairly small; large reviews often cost $250,000 per year A1c Results: Systematic Review CER for Guidelines Bennett W L et al. Ann Intern Med 2011;154:602-613 ©2011 by American College of Physicians Systematic Review CER as “Whistle Blowers” Expression before talking with GSK lawyers Expression after talking with GSK lawyers Systematic Review CER as “Whistle Blowers” Comparators Pooled OR of CV risk (95% CI) Metformin vs placebo or other med 0.85 (0.69 to 1.05) SU vs placebo or other med 0.89 (0.71 to 1.11) Pioglitazone vs placebo or other med 0.88 (0.78 to 1.00) Rosiglitazone vs placebo or other med 1.68 (0.92 to 3.06) Need long term observational studies to compare different medications effects on long term and safety outcomes (after adjusting for selection bias) Need standard reporting of outcomes in order to combine studies in meta-analyses Need to include patients with complications and comorbid illnesses which are often left out of RCTs Synthesizing indirect comparisons Incorporating patient input Assessing study applicability Psaty et al. JAMA AHRQ EPCs CDC Organizations such as SGIM, AHA, etc… NIH possibly (although more challenging) Systematic reviews are great opportunities for: ◦ Answering existing CER questions ◦ Setting up future CER studies ◦ Developing novel methodologies for CER, including incorporation of patient input